Anne Marie Junca

Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol

A. Hazout, Philippe Bouchard, David B. Seifer et al. · Fertility and Sterility · 2004 · 317 citations

Infertility, Andrology, Hormonal Contraceptive +11

Cytogenetic analysis and developmental capacity of normal and abnormal embryos after IVF

M Plachot, Jacqueline Mandelbaum, Anne Marie Junca et al. · Human Reproduction · 1989 · 79 citations

Oocyte, Fertility, Genetics +21

Paternal age and sperm DNA decay: discrepancy between chromomycin and aniline blue staining

Stéphanie Belloc, Moncef Benkhalifa, Anne Marie Junca et al. · Reproductive BioMedicine Online · 2009 · 50 citations · Full text

Spermatogenesis, Chromatin, Biology +14

Comparison between long and short protocols of LHRH agonist in the treatment of polycystic ovary disease by in-vitro fertilization

J Salat‐Baroux, S. Álvarez, J.-M. Antoine et al. · Human Reproduction · 1988 · 38 citations

“Physiologic” (hyaluronic acid-carried) ICSI results in the same embryo quality and pregnancy rates as with the use of potentially toxic polyvinylpyrrolidone (PVP)

Y. Ménézo, Anne Marie Junca, M Dumont et al. · Fertility and Sterility · 2010 · 19 citations · Full text

Toxic Polyvinylpyrrolidone, Fertility, Uterine Receptivity +14